Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

China Stock Movers: Beijing Capital, Gemdale, NARI, Staidson

Oct. 14 (Bloomberg) -- Shares of the following companies had unusual moves in China trading. Stock symbols are in parentheses and prices are as of the close in Shanghai.

The Shanghai Composite Index, which tracks the bigger of China’s stock exchanges, fell 0.3 percent to 2,431.38. The CSI 300 Index dropped 0.3 percent to 2,653.78.

Developers: Gemdale Corp. (600383 CH) slid 1.2 percent to 4.87 yuan. Poly Real Estate Group Co. (600048 CH), the second-biggest developer, slipped 0.2 percent to 9.30 yuan.

China’s inflation exceeded 6 percent for a fourth month, limiting the government’s ability to ease monetary policy as a weakening global recovery threatens growth in the world’s second-largest economy.

Beijing Capital Development Co. (600376 CH) fell 2.1 percent to 8.27 yuan. China Life and China Life Insurance (Group) Co. sold 77.85 million Beijing Capital shares from July 20 to Oct. 11 and may continue to sell their shares in the company in the next 12 months, according to a statement from a China Life unit to Shanghai’s stock exchange today.

Guoyuan Securities Co. (000728 CH) lost 0.9 percent to 10.56 yuan, the biggest decline since Sept. 30. The brokerage’s net income for the first nine months fell 32 percent to 459.4 million yuan, according to a statement to the Shenzhen Stock Exchange.

NARI Technology Development Co. (600406 CH) lost 7.5 percent to 32.82 yuan, the biggest drop in a year. NARI said 30 million shares will become tradable on Oct. 21, which account for 2.87 percent of the company’s total, according to a statement to the Shanghai Stock Exchange.

Staidson Beijing Biopharmaceuticals Co. (300204 CH) jumped 7.3 percent to 50.20 yuan, the biggest rally since July 28. The company’s net income may have climbed 95 percent to 115 percent in the third quarter, according to a statement to the Shenzhen Stock Exchange.

To contact Bloomberg News staff for this story: Irene Shen in Shanghai at ishen4@bloomberg.net

To contact the editor responsible for this story: Shiyin Chen at schen37@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.